RNS Number : 5260M
Cambridge Nutritional Sciences PLC
15 September 2023
 

Omega Diagnostics Group plc

(To be renamed Cambridge Nutritional Sciences PLC)

(the 'Company')

 

Change of Name

 

Further to the passing of the relevant resolution at the Company's Annual General Meeting, held 6 September 2023, the Company confirms the change of name to Cambridge Nutritional Sciences plc has now taken place and becomes effective on the London Stock Exchange today.

 

The Company's TIDM has been updated to CNSL, but its ISIN (GB00B1VCP282), SEDOL (B1VCP28) and LEI (2138007U9P4BTZTYIR92) numbers remain unchanged.

 

Shareholders should also note that their holdings of ordinary shares in the Company will not be affected by the change of name. Furthermore, existing share certificates should be retained as they remain valid for all purposes and new share certificates will not be issued.

 

AIM nominated advisor name change

The Company also notes that its nominated adviser and broker finnCap Ltd, has changed its name to Cavendish Capital Markets Limited.

 

-Ends-

 

Contacts: 

 

Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC)

 www.omegadx.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR







Cavendish Capital Markets Limited  

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)






Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus / Lianne Applegarth

Mob: 07980 541 893 / 07584 391 303

Sam Allen

Mob: 07502 558 258

 

 

About Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC)

Omega (AIM: ODX, to become CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFFFVIATISLIV